Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Chris Lange | Dec 27, 2018 at 10:00 AM EST

Short Sellers Hike Bets in Major Pharma Stocks

The December 14 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 12, 2018 at 9:50 AM EST

Major Pharma Stocks See a Surge in Short Interest

The November 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 8, 2018 at 7:20 AM EST

Major Health Care Catalysts Coming by the End of 2018

24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies…

Jon C. Ogg | Dec 6, 2018 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, American Water, Apple, Facebook, Macy’s, Southern Copper, Twitter, YY and Many More

The top analyst upgrades, downgrades and initiations seen on Thursday included Alphabet, American Water, Apple, Facebook, Macy's, Southern Copper, Twitter…

Chris Lange | Nov 28, 2018 at 9:00 AM EST

Short Sellers Hike Their Bets in Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 27, 2018 at 12:00 PM EST

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study.

Chris Lange | Nov 12, 2018 at 10:10 AM EST

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 21, 2018 at 10:15 AM EDT

Top Biotech Earnings Reports to Watch This Week

Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming…

Chris Lange | Oct 11, 2018 at 1:20 PM EDT

How Compugen Is Weathering Thursday’s Storm

Compugen shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb will make a $12 million equity investment…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

1 … 13 14 15 16 17 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Major Health Care Catalysts Coming by the End of 2018

Top Analyst Upgrades and Downgrades: Alphabet, American Water, Apple, Facebook, Macy’s, Southern Copper, Twitter, YY and Many More

Short Sellers Hike Their Bets in Major Pharma Stocks

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Major Pharma Short Sellers Hike Their Bets

Top Biotech Earnings Reports to Watch This Week

How Compugen Is Weathering Thursday’s Storm

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma Stocks

Short Sellers Back Off Major Pharma Stocks

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Major Health Care Catalysts Coming by the End of 2018

Top Analyst Upgrades and Downgrades: Alphabet, American Water, Apple, Facebook, Macy’s, Southern Copper, Twitter, YY and Many More

Short Sellers Hike Their Bets in Major Pharma Stocks

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Major Pharma Short Sellers Hike Their Bets

Top Biotech Earnings Reports to Watch This Week

How Compugen Is Weathering Thursday’s Storm

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma Stocks

Short Sellers Back Off Major Pharma Stocks

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do